Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Pharmaceuticals (MIST) Depreciation & Amortization (CF): 2018-2024

Historic Depreciation & Amortization (CF) for Milestone Pharmaceuticals (MIST) over the last 7 years, with Dec 2024 value amounting to $105,000.

  • Milestone Pharmaceuticals' Depreciation & Amortization (CF) fell 34.78% to $15,000 in Q4 2022 from the same period last year, while for Dec 2022 it was $89,000, marking a year-over-year decrease of 4.30%. This contributed to the annual value of $105,000 for FY2024, which is 14.13% up from last year.
  • Milestone Pharmaceuticals' Depreciation & Amortization (CF) amounted to $105,000 in FY2024, which was up 14.13% from $92,000 recorded in FY2023.
  • Milestone Pharmaceuticals' 5-year Depreciation & Amortization (CF) high stood at $105,000 for FY2024, and its period low was $89,000 during FY2022.
  • Its 3-year average for Depreciation & Amortization (CF) is $95,333, with a median of $92,000 in 2023.
  • In the last 5 years, Milestone Pharmaceuticals' Depreciation & Amortization (CF) soared by 155.26% in 2020 and then dropped by 4.30% in 2022.
  • Milestone Pharmaceuticals' Depreciation & Amortization (CF) (Yearly) stood at $97,000 in 2020, then dropped by 4.12% to $93,000 in 2021, then dropped by 4.30% to $89,000 in 2022, then rose by 3.37% to $92,000 in 2023, then grew by 14.13% to $105,000 in 2024.